Published in Diabetes Technol Ther on July 01, 2010
Systematically in silico comparison of unihormonal and bihormonal artificial pancreas systems. Comput Math Methods Med (2013) 0.82
Robustness of cellular functions. Cell (2004) 6.65
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care (2006) 5.20
Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell (2007) 4.87
Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes (2012) 3.40
Dynamic flux balance analysis of diauxic growth in Escherichia coli. Biophys J (2002) 3.10
Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care (2014) 3.00
A novel computational model of the circadian clock in Arabidopsis that incorporates PRR7 and PRR9. Mol Syst Biol (2006) 2.48
Modular artificial beta-cell system: a prototype for clinical research. J Diabetes Sci Technol (2008) 2.42
Robustness properties of circadian clock architectures. Proc Natl Acad Sci U S A (2004) 2.31
Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell. Diabetes Care (2007) 2.30
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care (2013) 2.26
Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care (2010) 2.18
Importance of input perturbations and stochastic gene expression in the reverse engineering of genetic regulatory networks: insights from an identifiability analysis of an in silico network. Genome Res (2003) 2.09
A benchmark for methods in reverse engineering and model discrimination: problem formulation and solutions. Genome Res (2004) 2.06
Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board. J Diabetes Sci Technol (2009) 2.06
Bolus calculator: a review of four "smart" insulin pumps. Diabetes Technol Ther (2008) 1.96
Identification of small molecule activators of cryptochrome. Science (2012) 1.95
Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care (2006) 1.95
Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Technol (2008) 1.81
Iterative approach to model identification of biological networks. BMC Bioinformatics (2005) 1.80
Proposal for the reconsideration of the definition of gestational diabetes. Diabetes Care (2005) 1.78
"Turn it off!": diabetes device alarm fatigue considerations for the present and the future. J Diabetes Sci Technol (2013) 1.77
Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker. Diabetes Technol Ther (2003) 1.74
New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time. Diabetes Technol Ther (2009) 1.71
Sensitivity analysis of discrete stochastic systems. Biophys J (2005) 1.70
Siphon effects on continuous subcutaneous insulin infusion pump delivery performance. J Diabetes Sci Technol (2010) 1.70
Clinical evaluation of a personalized artificial pancreas. Diabetes Care (2012) 1.69
Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care (2010) 1.66
Model-based blood glucose control for Type 1 diabetes via parametric programming. IEEE Trans Biomed Eng (2006) 1.63
Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events. J Diabetes Sci Technol (2010) 1.62
Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care (2012) 1.57
Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol (2009) 1.55
A molecular model for intercellular synchronization in the mammalian circadian clock. Biophys J (2007) 1.54
Point: Oral hypoglycemic agents should not be used to treat diabetic pregnant women. Diabetes Care (2007) 1.47
A model of the cell-autonomous mammalian circadian clock. Proc Natl Acad Sci U S A (2009) 1.46
The artificial pancreas: current status and future prospects in the management of diabetes. Ann N Y Acad Sci (2014) 1.44
Point: yes, it is necessary to rely entirely on glycemic values for the insulin treatment of all gestational diabetic women. Diabetes Care (2003) 1.43
Run-to-run control of blood glucose concentrations for people with Type 1 diabetes mellitus. IEEE Trans Biomed Eng (2006) 1.39
Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric. Diabetes Care (2007) 1.36
Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithms. Diabetes Technol Ther (2011) 1.34
Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther (2009) 1.34
A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes. J Process Control (2008) 1.31
In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. Diabetes Technol Ther (2009) 1.24
Run-to-run control of meal-related insulin dosing. Diabetes Technol Ther (2005) 1.24
Control-relevant models for glucose control using a priori patient characteristics. IEEE Trans Biomed Eng (2011) 1.23
Use of a novel fluorescent glucose sensor in volunteer subjects with type 1 diabetes mellitus. J Diabetes Sci Technol (2011) 1.21
Enhanced 911/global position system wizard: a telemedicine application for the prevention of severe hypoglycemia--monitor, alert, and locate. J Diabetes Sci Technol (2009) 1.20
In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus. J Diabetes Sci Technol (2009) 1.19
A neuropeptide speeds circadian entrainment by reducing intercellular synchrony. Proc Natl Acad Sci U S A (2013) 1.19
Advancement of the artificial pancreas through the development of interoperability standards. J Diabetes Sci Technol (2013) 1.18
Novel methodology to determine the accuracy of the OmniPod insulin pump: a key component of the artificial pancreas system. J Diabetes Sci Technol (2011) 1.18
Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol (2003) 1.15
Practical issues in the identification of empirical models from simulated type 1 diabetes data. Diabetes Technol Ther (2007) 1.15
Design of the health monitoring system for the artificial pancreas: low glucose prediction module. J Diabetes Sci Technol (2012) 1.14
Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther (2009) 1.12
Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus. Diabetes Technol Ther (2007) 1.10
Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care (2012) 1.10
A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. J Clin Epidemiol (2003) 1.09
Quest for the artificial pancreas: combining technology with treatment. IEEE Eng Med Biol Mag (2010) 1.09
Closed-loop control and advisory mode evaluation of an artificial pancreatic Beta cell: use of proportional-integral-derivative equivalent model-based controllers. J Diabetes Sci Technol (2008) 1.09